Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00035542 · ClinicalTrials.gov registry record · Phase 3
A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.
A Phase 3 study, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00035542: Completed Phase 3 study, sponsored by Bristol-Myers Squibb.
NCT00035542 is a Phase 3 study that has completed, run by Bristol-Myers Squibb. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00035542, a Phase 3 study, has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
The purpose of this clinical research study is to see if Glucovance, a medication currently approved for use in adults with type 2 diabetes, can control type 2 diabetes safely and effectively in children 9 to 16 years of age.
Interventions
- DRUG glyburide
- DRUG Glucovance (metformin HCl/glyburide)
- DRUG metformin HCl
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-12 |
| Est. Completion | 2003-10 |
| Phase | Phase 3 |
What the finished NCT00035542 record still lists
NCT00035542 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 3 interventions - of which glyburide is the first listed.
NCT00035542 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00035542 about?
NCT00035542 is a clinical study titled "A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.". The purpose of this clinical research study is to see if Glucovance, a medication currently approved for use in adults with type 2 diabetes, can control type 2 diabetes safely and effectively in children 9 to 16 years of age.
What is the current status of trial NCT00035542?
This trial is currently completed. It is a Phase 3 study. The study started on 2001-12. Estimated completion is 2003-10.
What interventions are being tested in trial NCT00035542?
The interventions under investigation include: glyburide (DRUG), Glucovance (metformin HCl/glyburide) (DRUG), metformin HCl (DRUG).
Who is sponsoring clinical trial NCT00035542?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia